Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Topical 5-Fluorouracil can rarely cause nerve damage, especially in people with a certain genetic deficiency.

Fluconazole-loaded hair gel may offer a longer-lasting dandruff treatment.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Clofazimine may be effective for treating ashy dermatosis.

Methotrexate is effective for rheumatoid arthritis but often causes side effects like nausea and liver issues.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Nail loss may be a side effect of the MS drug teriflunomide.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.